Pyrimethamine(RP4753)

Pyrimethamine(RP4753)

Use of pyrimethamine

Pyrimethamine(RP4753) is a medication used for protozoal infections; interferes with tetrahydrofolic acid synthesis from folic acid by inhibiting the enzyme dihydrofolate reductase (DHFR).IC50 Value: 15.4 nM (Plasmodium falciparum) [1]Target: DHFR; antifolatein vitro: Three susceptibility levels (susceptible, intermediate, and resistant) were observed in the response of culture-adapted clones and strains to pyrimethamine (50% inhibitory concentration [IC50]) < 100, 100-2,000, and > 2,000 nM) and cycloguanil (IC50 < 50, 50-500, and > 500 nM). Based on these susceptibility levels, 73 and 68 of 96 fresh clinical isolates were susceptible to pyrimethamine (mean IC50 15.4 nM) and cycloguanil (mean IC50 11.1 nM), respectively [1]. We tested pyrimethamine(previously reported to suppress SOD1 expression), several compounds currently in trials in human and murine ALS, and a set of 1040 FDA-approved compounds. In a PC12 cell-based assay, no compounds reduced SOD1 promoter activity without concomitant cytotoxicity. Additionally,pyrimethamine failed to repress levels of SOD1 protein in HeLa cells or homogenates of liver, spinal cord and brain of wild-type mice [3].in vivo: (131)I-Pyrimethamine (specific activity: 7.08 MBq/ mol) was injected intravenously into the tail vein of the control and infected rats. Static whole body images of the rats were acquired under the gamma camera at 5 min, 45 min, 2 h, 6 h, and 24 h following the intravenous administration of the radioactivity (3.7 MBq/rat) [2]. The 10-day treatment with 10mg/kg/day of fluconazole combined with 40/1mg/kg/day sulfadiazine and pyrimethamine resulted in 93% survival of CF1 mice acutely infected with the highly virulent T. gondii RH strain, versus 36% of mice treated with just sulfadiazine and pyrimethamine [4].Toxicity: Sulfadoxine/pyrimethamine is well tolerated as treatment and when used as intermittent preventive treatment in pregnant African women. Sulfadoxine/pyrimethamine is no longer used as prophylaxis because it may cause toxic epidermal necrolysis and Stevens Johnson syndrome [5].

CAS: 40064-34-4  4-Piperidone monohydrate hydrochloride

CAS: 459-03-0           (4-Fluorophenyl)acetone
 
CAS:6080-56-4             Lead acetate trihydrate;Acetic acid

CAS:96-48-0         2-oxo-tetrahydrofurane

CAS: 64-17-5            Ethanol  

CAS:49851-31-2        2-bromo-1-phenylpentan-1-one

  CAS:103-63-9           Benzene, (2-bromoethyl)-

CAS:23076-35-9           Xylazine hydrochloride

CAS：103-81-1         Phenylacetamide

CAS: 99-92-3            4-Aminoacetophenone

CAS: 37148-48-4         4-Amino-3,5-dichloroacetophenone

CAS: 37148-47-3          4-Amino-3,5-dichlorophenacylbromide

CAS: 100-09-4         4-methoxybenzoic acid  

CAS: 100-07-2          4-Methoxybenzoyl chloride

CAS:23426-63-3        methyl 2-bromo-2-methylpropanoate

CAS:16595-80-5        Levamisole hydrochloride

CAS:5445-19-2          Methyl 2-Bromohexanoate

CAS:600-00-0           Ethyl 2-Bromoisobutyrate

CAS:1451-83-8         2-bromo-1-(3-methylphenyl)propan-1-one

CAS:49851-31-2         α-Bromovalerophenone
 
CAS:41979-39-9       4-oxopiperidinium chloride

CAS:56786-63-1       Spirostan-​6-​one, 3,​5-​dihydroxy-​, (3β,​5α,​25R)​-       
 
CAS:593-51-1           methylamine hydrochloride
 
CAS:5337-93-9         4-methylpropiophenone  
 
CAS:73-78-9         lidocaine hydrochloride

137-58-6             Lidocaine

CAS:136-47-0         Tetracaine hydrochloride

CAS: 138-59-0          Shikimic acid

CAS:94-09-7   Benzocaine    

CAS:94-15-5            Dimethocaine (Larocaine)

CAS:94-24-6            tetracaine

CAS:23239-88-5         ethyl 4-aminobenzoate,hydrochloride  

CAS:4584-49-0     2-(Dimethylamino)Isopropyl Chloride Hydrochloride

CAS:705-60-2          2-nitro-1-phenyl-1-propene

131707-25-0        ethyl 6-bromo-4-[(dimethylamino)methyl]  

CAS:78-67-1          2,2'-Azobis(2-methylpropionitrile)

CAS:  2893-78-9              Sodium dichloroisocyanurate